The Impact of UGT1A1 Genetic Variability on Enzyme Expression in Liver Pathology
Genes · 2026
DOI: 10.3390/genes17050589 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Sylwia Szeląg-Pieniek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Pharmacology, Pomeranian Medical University, Al. Powstańców Wlkp. 72, 70-111 Szczecin, Poland. Hauptthemen laut MEDLINE: Glucuronosyltransferase, Liver, Liver Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Glucuronidation is a major phase II biotransformation reaction responsible for the inactivation and elimination of endogenous compounds and pharmaceuticals. This process is catalyzed by enzymes belonging to the UDP-glucuronosyltransferase (UGT) family, among which UGT1A1 is the most extensively studied. UGT1A1 plays a critical role in the metabolism of numerous drugs and is essential for bilirubin glucuronidation. Due to this specific function, it has significant clinical relevance, as impaired enzyme activity resulting from genetic polymorphisms or mutations can lead to the accumulation of unconjugated bilirubin in the bloodstream. This study aimed to evaluate the association between the UGT1A1*28 allele and the gene expression and protein levels in human liver tissue, in relation to different liver diseases.
Methods
Liver tissues were obtained from patients with various liver pathologies and the control group consisted of tissues showing no pathological symptoms. A total of 143 patients were included in the study. Pyrosequencing was used to analyze PCR products for the UGT1A1*28 polymorphism (variable number of TA repeats in the TATA sequence of the promoter).
Results
In both the control and study groups, UGT1A1 gene expression at the mRNA level and protein concentration in liver tissue decreased with the increasing number of UGT1A1*28 alleles. The association between UGT1A1 genotype and mRNA/protein content was most pronounced in HCV and AIH, and slightly weaker in the ALK and PBC groups. The significant association between UGT1A1*28 allele and bilirubin concentration was observed in control group but not in liver pathology.
Conclusions
The UGT1A1*28 polymorphism is associated with reduced hepatic mRNA and protein abundance in patients with liver disease. However, the significance of this observation for the metabolism of the enzyme substrates should be further investigated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental and Clinical Pharmacology, Pomeranian Medical University, Al. Powstańców Wlkp. 72, 70-111 Szczecin, Poland.
- Independent Pharmacodynamics Laboratory, Pomeranian Medical University, pl. Polskiego Czerwonego Krzyża 1, 71-244 Szczecin, Poland.
- Department of Pharmacokinetics and Monitored Therapy, Pomeranian Medical University, Al. Powstańców Wlkp. 72, 70-111 Szczecin, Poland.
- Institute of Pharmacology and Toxicology, Rostock University Medical Center, 18057 Rostock, Germany.
ORCID-Profile: Damian Malinowski, Stefan Oswald, Marek Droździk, Mateusz Kurzawski
Zitieren
APA
Szeląg-Pieniek, S., Kucak, J., Malinowski, D., Oswald, S., Droździk, M., & Kurzawski, M. (2026). The Impact of UGT1A1 Genetic Variability on Enzyme Expression in Liver Pathology. Genes. https://doi.org/10.3390/genes17050589
Vancouver
Szeląg-Pieniek S, Kucak J, Malinowski D, Oswald S, Droździk M, Kurzawski M. The Impact of UGT1A1 Genetic Variability on Enzyme Expression in Liver Pathology. Genes. 2026. doi:10.3390/genes17050589
BibTeX
@article{SzelgPieniek2026,
author = {Szeląg-Pieniek, Sylwia and Kucak, Joanna and Malinowski, Damian and Oswald, Stefan and Droździk, Marek and Kurzawski, Mateusz},
title = {The Impact of UGT1A1 Genetic Variability on Enzyme Expression in Liver Pathology},
journal = {Genes},
year = {2026},
doi = {10.3390/genes17050589}
}
EUVIMED